View Older Stories View More Recent Stories
-
Himax Technologies (HIMX) PT Raised to $4 at Roth Capital
-
UPDATE: Roth Capital Starts Kodiak Sciences Inc. (KOD) at Buy
-
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
-
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
-
First Solar (FSLR) Class Action Settlement 'Positive' - Roth Capital
-
Plug Power (PLUG) Award Raises Growth Visibility, Expect More - Roth Capital
-
Roth Capital Downgrades Coeur d'Alene Mines (CDE) to Sell
-
Darling International (DAR) PT Raised to $38 at Roth Capital, Top Pick for 2020
-
Musk defies skeptics, meets Tesla delivery goal; shares hit record
-
Renewable Energy Group (REGI) PT Raised to $33 at Roth Capital
-
Roth Capital Reiterates Buy Rating on Sequans Communications (SQNS), Says Co To Be Top Semi/IoT Performer in 2020
-
Arcimoto Inc. (FUV) PT Lowered to $5 at Roth Capital
-
UPDATE: Roth Capital Transfers Coverage on Zynerba Pharmaceuticals (ZYNE) at Buy
-
Roth Capital Downgrades AquaVenture Holdings (WAAS) to Neutral Following Acquisition
-
Roth Capital Downgrades AquaVenture Holdings (WAAS) to Neutral
-
Roth Capital Starts Crinetics (CRNX) at Buy
-
Roth Capital Starts Oxurion NV (OXUR:BB) (TBGNF) at Buy
-
NV5 Completes the Acquisition of Quantum Spatial, Schedules January 7 Conference Call to Discuss Strategic Benefits
-
Roth Capital Starts Cresco Labs Inc. (CL:CN) (CRLBF) at Buy
-
Pre-Open 12/19: (PRTK) (RAD) (TIVO) Higher (NERV) (APOG) (XPER) Lower (more...)
-
After-Hours Movers 12/18: (AMPE) (NBEV) (MU) Higher; (NERV) (MLHR) (GDOT) Lower (more...)
-
Roth Capital Starts Inovio Pharmaceuticals (INO) at Buy
-
UPDATE: Roth Capital Starts X4 Pharmaceuticals (XFOR) at Buy
-
Roth Capital Starts Yeti Holdings Inc. (YETI) at Buy
-
Akoustis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Akoustis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Exclusive: ProSieben's NuCom looks at Meet Group acquisition - sources
-
Azure Power Global Limited (AZRE) PT Raised to $24 at Roth Capital
-
Roth Capital Starts SiTime Corp. (SITM) at Buy
-
Organovo (ONVO) and Tarveda Therapeutics Announce Definitive Merger Agreement
-
Organovo and Tarveda Therapeutics Announce Definitive Merger Agreement
-
Amarin Corporation (AMRN) Get's A Wider Label 2 Weeks Before PDUFA - Roth Capital
-
Beyond Air, Inc. Announces Closing of $11.5 Million Public Offering and Private Placement of Common Stock and Exercise of Option to Purchase Additional Shares
-
Tilray (TLRY) Overcomes Hurdles to International Distribution - Roth Capital
-
Akoustis Technologies (AKTS) Prices 4.8M Share Common Offering at $6.25/Sh
-
Akoustis Announces Pricing of Public Offering of Common Stock
-
Akoustis Announces Pricing of Public Offering of Common Stock
-
Forty Seven (FTSV) Prices 4.86M Share Common Offering ar $35/Sh
-
Forty Seven, Inc. Prices Underwritten Public Offering of 4,860,000 Shares of Common Stock
-
Forty Seven, Inc. Prices Underwritten Public Offering of 4,860,000 Shares of Common Stock
-
Beyond Air, Inc. (XAIR) Prices $10.5 Million Underwritten Offering of Common Stock and Concurrent Private Placement
-
Beyond Air Prices $10.5 Million Underwritten Offering of Common Stock and Concurrent Private Placement
-
Roth Capital Downgrades ArQule (ARQL) to Neutral
-
Roth Capital Resumes Gentherm Incorporated (THRM) at Buy
-
Plug Power (PLUG) Prices 40M Shares at $2.75
-
Plug Power Inc. Announces Pricing of Public Offering of Common Stock
-
Plug Power Inc. Announces Pricing of Public Offering of Common Stock
-
Marker Therapeutics (MRKR) PT Lowered to $8 at Roth Capital After Investment Conference Presentation

